Page 48 - Ohnson Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The European Commission said on Monday that the reduction in deliveries of COVID-19 vaccines from Johnson & Johnson to EU member states was only temporary, and the company was still due to meet its contract for total doses by the end of this year. "Member states were informed of certain delays when it comes to the delivery of Johnson & Johnson shots, and they expressed their concern," a spokesman for the European Union executive told a news conference.

Johnson & Johnson is not sure whether it will meet a target of delivering 55 million doses of its COVID-19 vaccine to the European Union by the end of the second quarter, the company's Dutch subsidiary said on Thursday. A spokeswoman for the healthcare conglomerate's Janssen pharmaceuticals unit confirmed a report by Dutch national broadcaster NOS that the target is in doubt due to production delays in the United States. The U.S. Food and Drug Administration halted production of J&J's vaccine at a plant owned by Emergent BioSolutions Inc in April after an inspection ...

20 million doses are expected to be delivered later this year

AstraZeneca and Johnson & Johnson's vaccines can cause "mutant" proteins to escape cells, triggering a response in blood vessels, the scientists say.

A Facebook post claims there are no peer-reviewed studies on the safety and efficacy of the COVID-19 vaccines. That is false.